Avantor Inc at Evercore ISI HealthCONx Conference Transcript

Dec 02, 2020 / 07:40PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD

Okay. Thanks, everyone, for joining us this afternoon. A real pleasure to have the management team from Avantor with us this afternoon. Representing the company, we have the CEO, Michael Stubblefield. Michael, welcome to the conference. It's good to see you albeit virtually. Hopefully, at some point, I'll get to see you in person and I think a lot of that depends upon how Avantor can help us on the vaccine front. So we'll get into the vaccine front in a bit. But perhaps, let's start with the second wave and that's been a topical question for most folks with the rising cases.

Questions and Answers:

Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD

Have you seen any impact on the business? How has Q4 played out so far? Has it been in line within the range of expectations for Avantor?

Michael Stubblefield - Avantor, Inc. - President, CEO & Director

Yes. Vijay, firstly, thanks for having this
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot